Shining some light on the obscure proteome
Chemoproteomics draw the target landscape of HDAC drugs
Advertisement
Mass-spectrometry based proteomics is the big-data science of proteins that allows the monitoring of the abundance of thousands of proteins in a sample at once. Therefore, it is a particularly well-suited readout for discovering which proteins are targeted by any small molecule. An international research team has investigated this using chemical proteomics.
Group Leader in Chemical Proteomics, Dr. Guillaume Médard, and his research group in the lab.
Uli Benz / TUM
Histone deacetylase (HDAC) inhibitors are a class of drugs used in oncology. An international research team involving scientists at the Technical University of Munich (TUM), Cornell University in Ithaca (USA), the German Cancer Research Center (DKFZ) in Heidelberg and Martin Luther University of Halle-Wittenberg has now investigated the effects of some HDAC drugs in more detail. The scientists researched whether those epidrugs affect proteins other than the HDACs which they are designed to inhibit.
“To do so, target deconvolution by chemical proteomics is the method of choice. Hence, we first made new chemical tools - the so called affinity matrices - that would allow us to systematically profile the HDACs,” explains Dr. Guillaume Médard, group leader for chemical proteomics at the TUM chair of Proteomics and Bioanalytics led by Prof. Bernhard Küster.
Profiling HDAC drugs by chemical proteomics
“I profiled 53 drugs and most of them, but not all, hit their intended HDAC target,” stated Severin Lechner, a doctoral candidate at the TUM School of Life Sciences. “There were, however, some surprises. Drugs used in hundreds of scientific studies were not as selective as it had been assumed. Many had additional targets that were not previously known.
These results highlight the power of proteomic approaches, as they can probe the binding to thousands of proteins at once. Finally, the team identified several molecules with outstanding selectivity, making them the inhibitors of choice for future scientific studies.
The target landscape of HDAC drugs
“The most unexpected finding was that MBLAC2 is off-target for half of the profiled molecules,” Lechner continues. This protein is not well characterized. Coincidentally, the team of Prof. Maurine Linder in Cornell researched on it at the same time. The two groups collaborated and confirmed that the protein is indeed hindered in performing its function in presence of the drugs.
Working with the group of Prof. Michael Pfaffl at TUM, Lechner examined the hinted unexplained phenotypic effects of some drugs and proved that MBLAC2 inhibition or knock-down leads to an accumulation of extracellular vesicles in the extracellular space. Extracellular vesicles are small membrane-bounded particles secreted by cells and transported through the whole body to transmit biomolecules and information between cells and tissues.
Fundamental research to make tomorrow’s epidrugs
“We are excited because we have uncovered a new player in this field of biology that notably encompasses exosomes, which play crucial roles in neurology, immunology and oncology,” explains Médard. “We are now designing molecules that only hit MBLAC2 so that we can probe this obscure protein in a range of model systems.”
This study will be useful to those who want to use HDAC inhibitors for probing biology or for therapeutic use. It helps in choosing the right chemical tool. It is also a valuable set of data for medicinal chemists who need to understand how chemical structures relate to potency and selectivity to make tomorrow’s epidrugs.
Original publication
Other news from the department science
Most read news
More news from our other portals
See the theme worlds for related content
Topic World Mass Spectrometry
Mass spectrometry enables us to detect and identify molecules and reveal their structure. Whether in chemistry, biochemistry or forensics - mass spectrometry opens up unexpected insights into the composition of our world. Immerse yourself in the fascinating world of mass spectrometry!
Topic World Mass Spectrometry
Mass spectrometry enables us to detect and identify molecules and reveal their structure. Whether in chemistry, biochemistry or forensics - mass spectrometry opens up unexpected insights into the composition of our world. Immerse yourself in the fascinating world of mass spectrometry!
Last viewed contents
Unchartered territory in the human genome
Comparison of two nano rulers - Study compares two methods for distance measurement in motile proteins
Imaging the dynamic cellular zoo made easier - This work will expand the ability to simultaneously monitor many processes in cells
How artificial intelligence can improve protein detection - Using AI to move the boundaries of microscopy
Novel AI-based software enables quick and reliable imaging of proteins in cells - Researchers programmed a tool that accurately recognises and picks proteins in electron cryo-tomography, substituting troublesome hand selection
Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing
Researchers show that introduced tardigrade proteins can slow metabolism in human cells
New technique expands tissues so hundreds of biomolecules can be seen inside cells
What the sea spider genome reveals about their bizarre anatomy - The first high-quality pycnogonid genome provides novel insights in chelicerate evo-devo
More than 100-year-old flu virus sequenced - Swiss Genome of the 1918 Influenza Virus Reconstructed
Attracting bright and bold minds: new ideas for genome diagnostics and single molecule sensing - Four innovative life sciences ideas with particular economic potential receive awards
